A recent preprint by Michele Mutti and colleagues reveals that phage activity against Staphylococcus aureus is severely impaired in plasma and synovial fluid. Coagulation factors binding to the bacteria form clots that protect them from phages, posing fundamental challenges for phage therapy in S. aureus infections.